Rhode Islanders' attitudes towards the development of a statewide genetic biobank

Personalized Medicine

Volumn 5, Issue 4, 2008, Pages 339-359

  Goldman, Roberta E ^a   Kingdon, Caroline ^a   Wasser, Jared ^a   Clark, Melissa A ^a   Goldberg, Robert ^b   Papandonatos, George D ^c   Hawrot, Edward ^a   Koren, Gideon ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Biobank; Biospecimen storage; Genetic analysis; Mixed methods feasibility study; Personalized medicine; Sudden cardiac arrest; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; BIOBANK; BLOOD SAMPLING; BLOOD STORAGE; CARDIOVASCULAR DISEASE; COMPUTER SECURITY; CONFIDENTIALITY; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC SCREENING; HEALTH CARE FACILITY; HEART ARREST; HUMAN; INFORMED CONSENT; LIFESTYLE; MALE; MEDICAL ETHICS; MEDICAL RECORD; MEDICAL RESEARCH; PATIENT INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; RACISM; UNITED STATES;

EID: 50549083476     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.5.4.339     Document Type: Article

References (63)

1. Troyer D: Biorepository standards and protocols for collecting, processing, and storing human tissues. Methods Mol. Biol. 441, 193-220 (2008).
2. Eiseman E, Bloom G, Brower J, Clancy N, Olmsted S: Case Studies of Existing Human Tissue Repositories: "Best Practices" for a Biospecimen Resource for the Genomic and Proteomic Era. Rand Corporation, CA, USA (2003).
3. Elcioglu HN, Berry AC: Fraser syndrome: diagnosed in a 50-year-old museum specimen. Am. J. Med. Genet. 94(3), 262-264 (2000).
4. Bauer K, Taub S, Parsi K: Ethical issues in tissue banking for research: a brief review of existing organizational policies. Theor. Med. Bioeth. 25(2), 113-142 (2004).
5. Ashburn TT, Wilson SK, Eisenstein BI: Human tissue research in the genomic era of medicine: balancing individual and societal interests. Arch. Intern. Med. 160(22), 3377-3384 (2000).
6. Martin JB, Kasper DL: In whose best interest? Breaching the academic-industrial wall. N. Engl. J. Med. 343(22), 1646-1649 (2000).
7. de Paoli P: Future of biobanking in microbiology for medical research. Future Microbiol. 3(1), 79-86 (2008).
8. Ginsburg GS, Burke TW, Febbo P: Centralized biorepositories for genetic and genomic research. JAMA 299(11), 1359-1361 (2008).
9. International Society for Biological and Environmental Repositories: Best practices for repositories I: collection, storage, and retrieval of human biological materials for research. Cell Preserv. Technol. 3(1), 5-48 (2005).
10. The Secretary's Advisory Committee on Genetics, Health and Society: Policy Issues Associated with Undertaking a Large U.S. Population Cohort Project on Genetics, Environment, and Disease. NIH Office of Biotechnology Activities, MD, USA (2007).
11. Priori SG, Schwartz PJ, Napolitano, C et al.: Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348(19), 1866-1874 (2003).
12. Moss AJ, Kass RS: Long QT syndrome: from channels to cardiac arrhythmias. J. Clin. Invest. 115(8), 2018-2024 (2005).
13. Brunner M, Peng X, Liu GX et al.: Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J. Clin. Invest. 118(6), 2246-2259 (2008).
14. Cambon-Thomsen A: Assessing the impact of biobanks. Nat. Genet. 34(1), 25-26 (2003).
15. de Montgolfier S, Moutel G, Duchange N et al.: Evaluation of biobank constitution and use: multicentre analysis in France and propositions for formalising the activities of research ethics committees. Eur. J. Med. Genet. 49(2), 159-167 (2006).
16. Haga SB, Beskow LM: Ethical, legal, and social implications of biobanks for genetics research. Adv. Genet. 60, 505-544 (2008).
17. Medicine's new central bankers. The Economist, 10th December (2005).
18. Maschke KJ: Navigating an ethical patchwork - human gene banks. Nat. Biotechnol. 23(5), 539-545 (2005).
19. Rothstein MA: Expanding the ethical analysis of biobanks. J. Law Med. Ethics 33(1), 89-101 (2005).
20. Clayton EW: Informed consent and biobanks. J. Law Med. Ethics 33(1), 15-21 (2005).
21. Shickle D: The consent problem within DNA biobanks. Stud. Hist. Philos. Biol. Biomed Sci. 37(3), 503-519 (2006).
22. Wendler D: One-time general consent for research on biological samples. BMJ 332(7540), 544-547 (2006).
23. Sridhar D: Inequalities in the United States Healthcare System. Human Development Report Office, NY, USA (2005).
24. Swede H, Stone CL, Norwood AR: National population-based biobanks for genetic research. Genet. Med. 9(3), 141-149 (2007).
25. Petersen A: Securing our genetic health: engendering trust in UK Biobank. Sociol. Health Illn. 27(2), 271-292 (2005).
26. Zheng ZJ, Croft JB, Giles WH, Mensah GA: Sudden cardiac death in the United States, 1989 to 2001. Circulation 104(18), 2158-2163 (1998).
27. Genetic Screening Avisory Committee: Annual Report. Department of Health, RI, USA (2000).
28. Borkan J: Doing qualitative research. In: Immersion/ Crystallization. Crabtree BM, Miller WL (Eds). Sage Publications, CA, USA, 179-194 (2000).
29. Groves R: Nonresponse bias in household surveys. Public Opin. Q. 70, 637-645 (2006).
30. Curran WJ: The tuskegee syphilis study. N. Engl. J. Med. 289(14), 730-731 (1973).
31. Skirton H, Frazier LQ, Calvin AO, Cohen MZ: A legacy for the children - attitudes of older adults in the United Kingdom to genetic testing. J. Clin. Nurs. 15(5), 565-573 (2006).
32. Frazier L, Calvin AO, Mudd GT, Cohen MZ: Understanding of genetics among older adults. J. Nurs. Scholarsh. 38(2), 126-132 (2006).
33. Levitt M, Weldon S: A well placed trust?: public perceptions of the governance of DNA databases. Crit. Public Health 15(4), 311-321 (2005).
34. Kettis-Lindblad A, Ring L, Viberth E, Hansson MG: Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? Eur. J. Public Health 16(4), 433-440 (2006).
35. McQuillan GM, Porter KS, Agelli M, Kington R: Consent for genetic research in a general population: the NHANES experience. Genet. Med. 5(1), 35-42 (2003).
36. Sanner JE, Frazier L: Factors that influence characteristics of genetic biobanks. J. Nurs. Scholarsh. 39(1), 25-29 (2007).
37. The Secretary's Advisory Committee on Genetics, Health and Society: The Draft Report on Policy Issues Associated with Undertaking a Large U.S. Population Cohort Project on Genetics, Environment, and Disease. NIH Office of Biotechnology Activities, MD, USA (2006).
38. Wendler D, Kington R, Madans J et al.: Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 3(2), E19 (2006).
39. Sheppard VB, Cox LS, Kanamori MJ et al.: Brief report: if you build it, they will come: methods for recruiting Latinos into cancer research. J. Gen. Intern. Med. 20(5), 444-447 (2005).
40. Katz RV, Kegeles SS, Kressin NR et al.: Awareness of the Tuskegee Syphilis Study and the US presidential apology and their influence on minority participation in biomedical research. Am. J. Public Health 98(6), 1137-1142 (2008).
41. McCallum JM, Arekere DM, Green BL, Katz RV, Rivers BM: Awareness and knowledge of the U.S. Public Health Service syphilis study at Tuskegee: implications for biomedical research. J. Health Care Poor Underserved 17(4), 716-733 (2006).
42. Kaiser J: Genomic medicine. African-American population biobank proposed. Science 300(5625), 1485 (2003).
43. Hoeyer K, Olofsson BO, Mjörndal T, Lynöe N: Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research. Scand. J. Public Health 32(3), 224-229 (2004).
44. Wendler D: One-time general consent-for research on biological samples: is it compatible with the health insurance portability and accountability act? Arch. Intern. Med. 166(14), 1449-1452 (2006).
45. Barr M: "I'm not really read up on genetics"; biobanks and the social context of informed consent. BioSocieties 1(2), 251-262 (2006).
46. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM: Trends in ethical and legal frameworks for the use of human biobanks. Eur. Respir. J. 30(2), 373-382 (2007).
47. Ducoumau P: The viewpoint of DNA donors on the consent procedure. New Genet, Soc. 26(1), 105-116 (2007).
48. Hansson MG, Diliner J, Bartram CR, Carlson A Helgesson G: Should donors be allowed to give broad consent to future biobank research? Lancet Oncol. 7(3), 266-269 (2006).
49. Artizzu F: The informed consent aftermath of the genetic revolution. An Italian example of implementation. Med. Health Cate Philos. (2007)
50. Porteri C, Bony P: A proposal for a model of informed consent for the collection, storage and use of biological materials for research purposes. Patient Educ. Couns. 71(1), 136-142 (2008).
51. Kaufman D, Geller G, Leroy L, Murphy J, Scott J, Hudson K: Ethical implications of including children in a large biobank for genetic-epidemiologic research: a qualitative study of public opinion. Am. J. Med. Genet. C Semin. Med. Genet. 148(C1), 31-39 (2008).
52. Heigesson G, Johnsson L: The right to withdraw consent to research on biobank samples. Med. Health Care Philos. 8(3), 315-321 (2005).
53. Eriksson S, Heigesson G: Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur. J. Hum. Genet. 13(9), 1071-1076 (2005).
54. Royse SD: Implications of genetic testing for sudden cardiac death syndrome. Br. J. Nurs. 15(20), 1104-1107 (2006).
55. Heart Rhythin UK Familial Sudden Death Syndromes Statement Development Group: Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. Heart 94(4). 502-507 (2008).
56. Langer G: About response rates. Public Perspective May/June, 16-18 (2003).
57. Bickart B, Schmittlein D: The distribution of survey contact and participation in America: constructing a survey-based estimate. J. Mark. Res. 36(2), 286-294 (1999).
58. Zipes DP: Epidemiology and mechanisms of sudden cardiac death. Can. J. Cardiol. 21 (Suppl. A), A37-A40 (2005).
59. Greenberg H, Case RB, Moss AJ et al.: Analysis of mortality events in the Multicenter Automatic Deflbrillator Implantation Trial (MADIT-II). J. Am. Coll. Cardiol. 43(8), 1459-1465 (2004).
60. Buxton AE, Lee KL, Hafley GE et al.: A simple model using the MUSTT database can stratify total mortality and sudden death risk of coronary disease patients. J. Am. Coll. Cardiol. 43(Suppl.), A425 (2004).
61. Weiss JN, Karma A, Shiferaw Y, Chen PS, Garfinkel A, Qu Z: From pulsus to pulseless: the saga of cardiac alternans. Circ. Res. 98(10), 1244-1253 (2006).
62. Roden DM: Clinical practice. Long-QT syndrome. N. Engl. J. Med. 358(2). 169-176 (2008).
63. Lehnart SE, Ackerman MJ, Benson DW Jr et al.: Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 116(20), 2325-2345 (2007).